ZYGEL Trademark

Trademark Overview


On Wednesday, August 16, 2017, a trademark application was filed for ZYGEL with the United States Patent and Trademark Office. The USPTO has given the ZYGEL trademark a serial number of 87571145. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 7, 2022. This trademark is owned by Zynerba Pharmaceuticals, Inc.. The ZYGEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders...
zygel

General Information


Serial Number87571145
Word MarkZYGEL
Filing DateWednesday, August 16, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZynerba Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDevon, PA 19333

Party NameZynerba Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDevon, PA 19333

Trademark Events


Event DateEvent Description
Monday, March 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 12, 2021EXTENSION 5 GRANTED
Wednesday, June 30, 2021EXTENSION 5 FILED
Thursday, July 8, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 30, 2021TEAS EXTENSION RECEIVED
Wednesday, January 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 4, 2021EXTENSION 4 GRANTED
Monday, January 4, 2021EXTENSION 4 FILED
Monday, January 4, 2021TEAS EXTENSION RECEIVED
Wednesday, June 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 8, 2020EXTENSION 3 GRANTED
Monday, June 8, 2020EXTENSION 3 FILED
Monday, June 8, 2020TEAS EXTENSION RECEIVED
Thursday, January 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 28, 2020EXTENSION 2 GRANTED
Tuesday, January 28, 2020EXTENSION 2 FILED
Tuesday, January 28, 2020TEAS EXTENSION RECEIVED
Tuesday, July 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 19, 2019EXTENSION 1 GRANTED
Friday, July 19, 2019EXTENSION 1 FILED
Friday, July 19, 2019TEAS EXTENSION RECEIVED
Tuesday, January 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 12, 2018TTAB RELEASE CASE TO TRADEMARKS
Wednesday, December 12, 2018OPPOSITION TERMINATED NO. 999999
Wednesday, December 12, 2018OPPOSITION DISMISSED NO. 999999
Wednesday, April 25, 2018OPPOSITION INSTITUTED NO. 999999
Wednesday, February 14, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 31, 2018ASSIGNED TO EXAMINER
Thursday, January 25, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 6, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 6, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 20, 2017ASSIGNED TO EXAMINER
Tuesday, August 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 21, 2017NEW APPLICATION ENTERED IN TRAM